What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (29 Viewers)

Bought WFC a year ago in our cash account (not retirement). Done very well, ~65%. Thinking I should sell it all and buy some of these guys on sale. Just don't want to pay taxes, but I'll have to face that music soon or later.

Talking decent $ here. 2,000 shares. WWYD?
Trade has happened. Sell half if you still want to own it…..start branching out into different stocks on sale.

 
Bought WFC a year ago in our cash account (not retirement). Done very well, ~65%. Thinking I should sell it all and buy some of these guys on sale. Just don't want to pay taxes, but I'll have to face that music soon or later.

Talking decent $ here. 2,000 shares. WWYD?


I had slightly more shares than that and took about 25% of it off the table last Friday after earnings when it was up 21% YTD. That was all in my 401k though, so no tax implications.

I think you have to assume at some point (anyone's guess) the asset cap gets lifted and the stock spikes on that catalyst. Not sure rates forecasts are going to keep moving higher. I just get nervous with so much of an investment in any single name.

 
Trade has happened. Sell half if you still want to own it…..start branching out into different stocks on sale.
Todem if you tax lost harvested RDS would you get back in after this jump? Go with a similar option or avoid the sector for now? Thanks buddy. 

 
Sold half my bank stocks (BEN, PBCT) and half my UUUU.  Locking in nice gains on these (though had I done this in Dec, I would have locked in nicer gains, but regardless, never grumble about a profit) to load up on FLGT.  I'm a believer. 

Also added more NKE.  I think $140 is a level of support and if the markets rebound, NKE has a lotta room to run.  

 
Bought WFC a year ago in our cash account (not retirement). Done very well, ~65%. Thinking I should sell it all and buy some of these guys on sale. Just don't want to pay taxes, but I'll have to face that music soon or later.

Talking decent $ here. 2,000 shares. WWYD?


I held a whooolllllllee lotta stuff at very high gains in December because I didn't want to pay taxes on it.

Really wishing I would've just bit the tax bullet now.  Lesson learned for me.

I really hate the way taxes work with this.  The government shouldn't be forcing us into making bad decisions to preserve our funds that we're not actually cashing out yet.  That really sucks.

 
Todem if you tax lost harvested RDS would you get back in after this jump? Go with a similar option or avoid the sector for now? Thanks buddy. 
No I would not. Wait for the inevitable pullback in oil as supply eventually catches up with demand and look at CVX on the pullback.

If you want a diversified play I suggested PEO back in March of 2020! Think that is up 110% since then.

 
Last edited by a moderator:
Brutal. The only real plus is this happening before we’ve funded the IRAs and my girlfriend’s solo 401k for the year. Added more SHOP and NVDA. Still think this might keep happening until we see January inflation numbers next month and learn supply chain issues have largely subsided. Hope I’m not wrong about that.

 
in for AMZN, NFLX, SHOP, FLGT, DIS. i know i didn't hit the bottoms, but  i don't want to get cute. hopefully in 3 years i will be able to stop drinking...

 
I know this, March 2020 there was panic everywhere including some of the most respected people in business.  More than likely a few weeks from now everybody will be in here wishing they bought more of the good names.

 
I know this, March 2020 there was panic everywhere including some of the most respected people in business.  More than likely a few weeks from now everybody will be in here wishing they bought more of the good names.
I liked March 2020 better because the market used a guillotine and it was over and I barely felt a thing. This time around, the market is cutting off a finger, smashing a toe, removing an eyeball, water-boarding, and using an adrenaline shot every time I’m going to pass out so I stay awake and feel everything.

 
Shoulda kept my DKNG short on a little longer.....Not that it would have brought me royal riches, but still.  

VRTX has been a frigging stalwart for me.  God, if they really have the cure for T1D this thing could NOEXPLODE!!1111

 
I am in for the $200. To be fair, I think we should use the Jan 20th closing price for both companies. I added Gamestop at $93 today as well, but it has since moved up nicely from that spot.

and here is hoping you crush your all in bet  of FLGT and this stock goes to crazy highs for you.


Not sure what to do here.  Offered the bet based on the numbers at the time of the offer.  If you take those, you are already up by 10% or so.

 
Cash is king so far in 2021.  I don’t think we have found the floor on the market yet.  Especially true on tech side,  thought about buying today, but feels like more red to come, hope I am wrong.

 
I liked March 2020 better because the market used a guillotine and it was over and I barely felt a thing. This time around, the market is cutting off a finger, smashing a toe, removing an eyeball, water-boarding, and using an adrenaline shot every time I’m going to pass out so I stay awake and feel everything.
Each day I check my portfolios and hear the ghost of Billy Mays yelling: But wait, there's more!

 
Bought a share of AMZN at the close for $2851.

Swore I wouldn't do it, but after today I've got plenty of time to wait it out as I'll be working another 3-5 years.

 
Down 4.04% today so don't feel quite so bad.  COIN, SE and FLGT being my biggest anchors.  FLGT my largest holding now as I can't stop buying at these prices.

 
LOL...I didn't have a ton of "cash" but unloaded a bunch of SPACs today.  Most were flat today and only down 5% all time.  Only losing 5% in that junk turned out to be a great play.

 
Down 4.04% today so don't feel quite so bad.  COIN, SE and FLGT being my biggest anchors.  FLGT my largest holding now as I can't stop buying at these prices.
I dont know jack squat about stonks, but someone mentioned FLGT had a huge amount of cash reserves, basically something like enough to pay shareholders 30 bucks per share and not even be in debt.

My question, has a stock ever had more cash reserves on hand than the value of its market cap?

 
Last edited by a moderator:
Stocks are never going up/down, until they do.   Corrections in this bull market haven't lasted long. 
True. But, looking at the 5 year chart of the NASDAQ doesn't give me warm fuzzies having my portfolio decimated and still 7,000 pts above where we were just 3 years ago. Seems like a massive gap still exists. Not a chart guy, but don't see why a retest would be out of the cards on a complete breakdown. I'm only 10% cash, so don't personally feel comfortable deploying anymore until a bottom is confirmed. Not sure where that will be, but I do know markets can be irrational either way and not confident stepping in front of a snowball rolling down hill.

 
Have moved from ~40% cash to ~50% cash in a month or two in a main account.. without even selling anything :lol:  

Getting close to DCA back in...  

 
I used to love stonks. Now I hate them. I know that this soon should change. 
 

I know you have to take a lot of what CNBC says with a grain of salt, but some smart lady said today that at least 80% of the trading is algorithms and computers. She said we can’t control that and there is no end in sight and.no bottom until those same algorithms induce a reversal, Did not make me feel any better. 

 
I used to love stonks. Now I hate them. I know that this soon should change. 
 

I know you have to take a lot of what CNBC says with a grain of salt, but some smart lady said today that at least 80% of the trading is algorithms and computers. She said we can’t control that and there is no end in sight and.no bottom until those same algorithms induce a reversal, Did not make me feel any better. 


:lmao:   at the bolded and I understand.  It's not fun but @Todem has been posting about this correction being a probable event since the beginning of December.  

Regarding the algorithms, shake out the weak hands, and there's a lot of them since the beginning of the pandemic, buy low. Rinse and repeat. 

 
It's fine. We will use your numbers. I answered that early in the day thinking you would be around. 


:hifive:

I'll send you a PM so we don't have to wade around for the post later.  Hopefully I'm sending you $200 when FLGT is sitting at $125 and GME is at $400

 
Cash is king so far in 2021.  I don’t think we have found the floor on the market yet.  Especially true on tech side,  thought about buying today, but feels like more red to come, hope I am wrong.
More red days ahead....100% guaranteed. But have a list of the big high quality tech you want and start nibbling Monday......NASDAQ is down 15% and many high quality cash flow positive names have been slaughtered. 

Stocks are never going up/down, until they do.   Corrections in this bull market haven't lasted long. 
That is correct. And we are still in a secular Bull Market. 

True. But, looking at the 5 year chart of the NASDAQ doesn't give me warm fuzzies having my portfolio decimated and still 7,000 pts above where we were just 3 years ago. Seems like a massive gap still exists. Not a chart guy, but don't see why a retest would be out of the cards on a complete breakdown. I'm only 10% cash, so don't personally feel comfortable deploying anymore until a bottom is confirmed. Not sure where that will be, but I do know markets can be irrational either way and not confident stepping in front of a snowball rolling down hill.
When you start seeing names like:

PG

MCD

GIS

CLX

AEP

KO

PEP

Join the bloodbath........that is a great “bat signal” we are forming a bottom.  So far these names along with industrials have been holding up.......but they are about to be thrown out with the bath water in this long over due and par for the course correction. 

NASDAQ is now down 15% from the all-time high and more is coming. 

The S&P 500 is  now down 8.75% from the all time high

And the Dow is about 7.25% down from the all time high.

We have some more to go....no doubt. 200 moving day averages have been breeched for both the NASDAQ and S&P 500.

Again.......have a list....check it twice....know what you want to own....figure out what price you feel presents great “LONG” term value and try not time bottoms. 

For you index investors......you gotta hold steady here and be patient if you have cash to deploy....the index's are not done yet selling off. We have not had a throwing in the towel moment yet.....the NASDAQ we are getting close to that. 

When you start seeing:

AMZN

GOOGL

FB

MFST

Getting ripped another clear sign of giving up. 

Bottom line is.....this is exactly what we talked about in our thesis and it will be temporary....and I fully expect a positive year in the market overall by year end.

It’s January 21st folks........

 
Last edited by a moderator:
P/E:  3.15

Too low for a bank or utility company.  

Cash to market cap: 61%

Actually I think this is probably closer to 75% at the moment but we'll have to wait 6 weeks for confirmation.

 
I dont know jack squat about stonks, but someone mentioned FLGT had a huge amount of cash reserves, basically something like enough to pay shareholders 30 bucks per share and not even be in debt.

My question, has a stock ever had more cash reserves on hand than the value of its market cap?
I'd be curious about this as well.  

 
Some Fulgent news from last month.

While we make it rain from Covid testing, let's detect cancer early...

HelioLiver™, an Innovative Liquid Biopsy Test for the Early Detection of Liver Cancer, is Now Commercially Available

HelioLiver can detect liver cancer in the earliest stages with a simple, non-invasive blood draw

HelioLiver is now available for patients through a provider order

IRVINE & TEMPLE CITY, Calif.--(BUSINESS WIRE)--Dec. 6, 2021-- Helio Health (“Helio”) and its commercial partner, Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), today announced the commercial launch of HelioLiver™, a multi-analyte blood test that incorporates cell free DNA (cfDNA) methylation patterns and serum protein markers for the detection of hepatocellular carcinoma (HCC) – the most common form of liver cancer. HelioLiver can detect HCC at its earliest stages when lesions are still very small, an area where traditional standard-of-care imaging tools often fall short, with the potential to enable more curative treatment options known to increase five-year survival rates by up to 13 times compared to when cancer has metastasized.1,2

Recent data presented at The Liver Meeting® 2021 outlined HelioLiver’s superior sensitivity over currently available blood-based tests. With a specificity of 91%, HelioLiver demonstrated 76% sensitivity in detecting early-stage HCC, significantly outperforming other detection tools such as AFP (57%), GALAD (65%), and ultrasound (47%).3,4

“We are excited to offer patients at high risk of developing liver cancer a convenient and sensitive serial testing option to catch cancer early when it counts the most,” said Justin Chen Li, U.S. Chief Executive Officer, Helio Health. “We are proud to partner with Fulgent to launch this innovative, simple, and reliable test that has the potential to redefine the future of cancer testing and foster better patient outcomes.”

HelioLiver offers a simplified process for patients with a blood draw that can be conducted during a routine check-up, providing a quick and accurate way to receive regular surveillance for people at risk of developing liver cancer. While the American Association for the Study of Liver Diseases (AASLD) guidelines recommend ultrasound screening every six months for patients who are at risk, studies have shown that as few as 20% of patients actually receive regular surveillance due to the inconvenience of accessing testing via ultrasound.5 Helio believes this number can dramatically increase with this new, blood-based test.

“Through our partnership with Helio, our joint priority is to bring HelioLiver to providers and patients in a seamless manner,” said Brandon Perthuis, Chief Commercial Officer, Fulgent Genetics. “Leveraging our extensive commercial infrastructure, we are well-positioned to deliver an easy ordering experience for providers with our representatives at the ready to provide the best-in-class white glove service throughout the entire experience.”

Providers can place orders online at HelioLiver.com/how-to-order, via phone (+1 626-350-0537) or email at info@helioliver.com to get connected with a representative.

For more information about HelioLiver and its clinical performance, please visit www.HelioLiver.com.

About Fulgent Genetics

Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent’s proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. Combining next generation sequencing with its technology platform, Fulgent performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. A cornerstone of our business is our ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated lab services.

About Helio Health

Helio Health is an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. The company’s mission is to simplify cancer screening so lives can be saved by detecting cancer earlier. With Helio’s AI-driven technology, both physicians and their patients gain powerful insights from accurate, accessible, and convenient blood tests.

Building on a robust research and development program, and with access to thousands of patient samples, the company is currently in clinical trials in the US and China with its lead liver cancer detection test. Helio’s development program is focused on liver, colon, breast and lung cancer.

Helio Health is headquartered in Irvine, CA, with R&D, GMP and CLIA facilities in Irvine, CA and West Lafayette, IN, Guangzhou and Beijing.

About Helio Health and Fulgent Genetics Partnership

In August 2021, Helio Health and Fulgent Genetics entered in a strategic partnership to co-brand and commercialize HelioLiver, a cell-free DNA (cfDNA) methylation blood test that incorporates protein markers and demographics for the detection of hepatocellular carcinoma (HCC) – or liver cancer. Fulgent will be responsible for laboratory operations, supply chain operations, marketing and sales leveraging its operational excellence and significant market reach, initially focused in the U.S. and Canada. Helio will provide intellectual property and continued support across research and development, publication development, market access and sales, as well as reimbursement operations. Fulgent and Helio will also collaborate on the development of additional liquid biopsy tests for different types of cancer in the future.

 

Users who are viewing this thread

Back
Top